A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer’s disease
Brain Res. 2011;1400:1-18
|Alzheimer’s disease (AD) is the most common form of dementia affecting the elderly. Even though several studies have demonstrated the pathogenic mechanism of AD, identification of proper drug targets based on such mechanisms has not been very successful. Moreover, current therapeutic options available are limited. Alzheimer’s disease is also called as a chronic inflammatory disease, as deposition of neurotoxin plaques and tangles results in inflammatory stress. Moreover, several study reports have shown that inflammation and apoptotic stress are the leading processes that are responsible for the devastating state of AD brain.|
Several naturally occurring chemopreventive agents have studied in the recent past to deal with increasing incidence and morbidity of cutaneous SCCa. Curcumin is the one compound that has been studied more recently in this regard. It has been well established that Curcumin acts as a chemopreventive agent in a variety of cancers, and thus its role in the treatment of skin cancer and other skin diseases has also been explored.
To explore the effect of a curcuminoid mixture and its individual components on inflammatory and apoptotic genes expression in AD using an Aβ+ibotenic acid-infused rat model.
Results and Discussion:
Curcuminoids, along with each constituent in the mixture played a significant role, via different pathways, in the attenuation of Aβ-induced apoptotic and inflammatory features, which clearly indicated their potential beneficial role in treating AD.